Exabis Library
Welcome to the e-CCO Library!
P382: Comparison of efficacy and safety of biosimilar infliximab to originator infliximab in children with inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P382: CRP/albumin ratio: Predictive factor of the response to corticosteroids in acute severe colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P382: High anti-tumor necrosis factor alpha treatment trough concentrations are not associated with higher rate of adverse events in pediatric patients with inflammatory bowel disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P382: Novel Image Enhanced Endoscopy (IEE) technologies for surveillance of colonic Inflammatory Bowel Disease: A pilot study evaluating Texture and Colour Enhancement Imaging (TXI) and Linked Colour Imaging (LCI) as compared with chromoendoscopy.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P382: Serum Ustekinumab Concentrations are Associated with Improved Outcomes with the Magnetic Resonance Index of Activity for Crohn's Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P383 The level of intestinal inflammation and fibrosis in resection specimens after preoperative anti-tumour necrosis factor-α treatment in patients with Crohn’s disease: a comparative pilot study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P383: Breast feeding practices differ between mothers with IBD and mothers without IBD
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P383: Increasing treatment time on REMICADE® (infliximab) predicts subsequent long-term retention in stable infliximab inflammatory bowel disease patients in Canada
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P383: One-year experience with ustekinumab in therapy-refractory or -intolerant patients with ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P383: Real-life experience of the efficacy, safety and pharmacokinetic data of switching from intravenous to subcutaneous infliximab in inactive inflammatory bowel disease patients. Results from the ENEIDA registry.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P383: Relationship between histo-endoscopic mucosal healing and baseline characteristics in patients with moderately to severely active Ulcerative Colitis receiving filgotinib in the phase 2b/3 SELECTION study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P383: Short- and long-term outcomes of infliximab and calcineurin inhibitor treatment for steroid-refractory ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P383: Ustekinumab as an opportunity for refractory Ulcerative Colitis patients.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P384 Lower infliximab trough levels are associated with higher bowel wall thickness in Crohn’s disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P384: A higher red blood cell methotrexate polyglutamate 3 concentration is associated with methotrexate drug-survival in patients with Crohn's Disease: first results of a prospective cohort
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P384: Gari-leo prospective study on anti-TNF therapy in ulcerative colitis relapse patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P384: High incidence of hyperglycaemia in steroid treated hospitalised inflammatory bowel disease (IBD) patients and its risk factors identified by machine learning methods
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P384: Long-term outcome and endoscopic healing rates following long modified side-to-side strictureplasties
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P384: Postoperative Endoscopic Recurrence In Patients With Crohn’s Disease After “Curative” Ileocecal Resection on Prophylaxis Treatment With Either Anti-TNFs, Vedolizumab or Ustekinumab: A Real-World Multicentre European Study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P384: The usefulness of salazosulfapyridine for
patients with ulcerative colitis refractory to mesalazine
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM